万泰生物(603392)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603392 万泰生物

午间休市 07-30 11:29:45

{"stockData":{"symbol":"603392","market":"SH","secType":"STK","nameCN":"万泰生物","latestPrice":59.24,"timestamp":1753846185000,"preClose":58.91,"halted":0,"volume":2347574,"delay":0,"changeRate":0.0056,"floatShares":1265000000,"shares":1265000000,"eps":-0.0572,"marketStatus":"午间休市","change":0.33,"latestTime":"07-30 11:29:45","open":59,"high":59.59,"low":58.68,"amount":139000000,"amplitude":0.0154,"askPrice":59.26,"askSize":41,"bidPrice":59.25,"bidSize":1,"shortable":0,"etf":0,"ttmEps":-0.0572,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753851600000},"marketStatusCode":3,"adr":0,"adjPreClose":58.91,"symbolType":"stock","openAndCloseTimeList":[[1753839000000,1753846200000],[1753851600000,1753858800000]],"highLimit":64.8,"lowLimit":53.02,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1265122774,"isCdr":false,"pbRate":6.1,"roa":"--","roe":"--","epsLYR":0.08,"committee":-0.390135,"marketValue":74946000000,"turnoverRate":0.0019,"status":0,"floatMarketCap":74946000000},"requestUrl":"/m/hq/s/603392","defaultTab":"news","newsList":[{"id":"2554711139","title":"每周股票复盘：万泰生物（603392）大宗交易金额达1198.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554711139","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554711139?lang=zh_cn&edition=full","pubTime":"2025-07-27 01:50","pubTimestamp":1753552216,"startTime":"0","endTime":"0","summary":"截至2025年7月25日收盘，万泰生物（603392）报收于59.74元，较上周的60.02元下跌0.47%。本周，万泰生物7月24日盘中最高价报61.99元。7月21日盘中最低价报59.07元。万泰生物当前最新总市值755.78亿元，在生物制品板块市值排名1/50，在两市A股市值排名199/5148。本周关注点交易信息汇总: 7月23日万泰生物发生1198.6万元的大宗交易交易信息汇总7月23日，万泰生物发生了金额为1198.6万元的大宗交易。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072700000190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1589","09633","BK1200","BK0239","603392","LU1981816686.USD"],"gpt_icon":0},{"id":"2554175033","title":"万泰生物：通过上市前检查的商业规模批次可上市销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2554175033","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554175033?lang=zh_cn&edition=full","pubTime":"2025-07-25 16:48","pubTimestamp":1753433294,"startTime":"0","endTime":"0","summary":"证券之星消息，万泰生物(603392)07月25日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，九价上市申请用来审核的疫苗是否可以直接销售，目前进度如何？万泰生物回复：您好！《药品生产监督管理办法》规定，通过相应上市前的药品生产质量管理规范符合性检查的商业规模批次，在取得药品注册证书后，符合产品放行要求的可以上市销售。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072500026910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","09633","LU1981816686.USD","BK1589","603392","BK1200"],"gpt_icon":0},{"id":"2553224931","title":"以诊断创新赋能全球健康万泰生物亮相吉隆坡WHX Labs 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2553224931","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553224931?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:01","pubTimestamp":1753318860,"startTime":"0","endTime":"0","summary":"万泰生物在吉隆坡WHX Labs 2025展会上展示其前沿诊断创新方案，包括化学发光、酶联免疫、胶体金等平台，吸引国际关注，并与东南亚医疗机构探讨合作，助力全球健康事业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724093625954fc016&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724093625954fc016&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2553159215","title":"7月23日万泰生物现1198.6万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2553159215","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553159215?lang=zh_cn&edition=full","pubTime":"2025-07-23 17:23","pubTimestamp":1753262598,"startTime":"0","endTime":"0","summary":"证券之星消息，7月23日万泰生物发生大宗交易，交易数据如下：大宗交易成交价格59.93元，成交20万股，成交金额1198.6万元，买方营业部为国金证券股份有限公司厦门湖滨南路证券营业部，卖方营业部为国金证券股份有限公司深圳分公司。近三个月该股共发生3笔大宗交易，合计成交1.02万手。截至2025年7月23日收盘，万泰生物报收于59.93元，上涨0.69%，换手率0.36%，成交量4.54万手，成交额2.71亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072300029254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","09633","LU1981816686.USD","BK1589","603392","BK1200"],"gpt_icon":0},{"id":"2552413134","title":"万泰生物获融资买入0.18亿元，近三日累计买入0.53亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552413134","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552413134?lang=zh_cn&edition=full","pubTime":"2025-07-19 08:02","pubTimestamp":1752883357,"startTime":"0","endTime":"0","summary":"7月18日，沪深两融数据显示，万泰生物获融资买入额0.18亿元，居两市第814位，当日融资偿还额0.26亿元，净卖出833.12万元。最近三个交易日，16日-18日，万泰生物分别获融资买入0.13亿元、0.22亿元、0.18亿元。融券方面，当日融券卖出0.38万股，净卖出0.38万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071908173897abaf3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071908173897abaf3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2552461156","title":"万泰生物中标23.72万元 金额占比小对业绩影响有限","url":"https://stock-news.laohu8.com/highlight/detail?id=2552461156","media":"自选股中标信息","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552461156?lang=zh_cn&edition=full","pubTime":"2025-07-18 18:21","pubTimestamp":1752834100,"startTime":"0","endTime":"0","summary":"2025年07月18日，据天眼查数据，邢台市中心血站酶免试剂采购项目F包补充合同显示，中标方为万泰生物，招标方为邢台市中心血站，金额23.72万元。财务影响方面，可参考公司2024年营收总额22.45亿元，本次中标金额占比较少。近半年内，万泰生物获得1家券商积极评价：国投证券给予\"增持\"评级。万泰生物主营业务涵盖试剂，疫苗，代理产品，其他收入之和。截至发稿，万泰生物股价报60.02元，上涨0.18%，成交额至2.13亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718182144a6b1f32c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718182144a6b1f32c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239"],"gpt_icon":0},{"id":"2552461153","title":"万泰生物中标1.10万元 金额较小对业绩影响有限","url":"https://stock-news.laohu8.com/highlight/detail?id=2552461153","media":"自选股中标信息","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552461153?lang=zh_cn&edition=full","pubTime":"2025-07-18 18:21","pubTimestamp":1752834090,"startTime":"0","endTime":"0","summary":"2025年07月18日，据天眼查数据，邢台市中心血站酶免试剂采购项目H包补充合同显示，中标方为万泰生物，招标方为邢台市中心血站，金额1.10万元。财务影响方面，可参考公司2024年营收总额22.45亿元，本次中标金额占比较少。近半年内，万泰生物获得1家券商积极评价：国投证券给予\"增持\"评级。万泰生物主营业务涵盖试剂，疫苗，代理产品，其他收入之和。截至发稿，万泰生物股价报60.02元，上涨0.18%，成交额至2.13亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718182133a453487a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718182133a453487a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239"],"gpt_icon":0},{"id":"2552453630","title":"生物疫苗概念盘中跳水，万泰生物跌0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552453630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552453630?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:48","pubTimestamp":1752803308,"startTime":"0","endTime":"0","summary":"07月18日，生物疫苗概念盘中跳水，截至09点48分，生物疫苗概念整体指数下跌1.02%，报2364.950点。从个股上来看，该概念的成分股中，万泰生物跌0.18%，天康生物、博雅生物、白云山跌幅居前。从资金上来看，截止发稿，生物疫苗概念主力净流入为-1.87亿，其中万邦德受到资金热捧，主力净流入1890.07万；拉长时间线来看，该板块近20日主力资金净流入-9.46亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718094828a6b0e67d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718094828a6b0e67d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239","159657"],"gpt_icon":0},{"id":"2551149002","title":"万泰生物：九价HPV疫苗市场定价为499元/支","url":"https://stock-news.laohu8.com/highlight/detail?id=2551149002","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551149002?lang=zh_cn&edition=full","pubTime":"2025-07-16 17:27","pubTimestamp":1752658027,"startTime":"0","endTime":"0","summary":"证券之星消息，万泰生物(603392)07月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问九价HPV疫苗市场定价是多少？什么时候能在市场上看到或打上？万泰生物回复：您好！九价HPV疫苗市场定价为499元/支。公司已按既定计划有序推动批签发，并严格按各省级疫苗管理部门制定的招\\补标以及准入规则推进工作。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600028065.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159646","BK1200","603392","09633","BK1589","BK0239","LU1981816686.USD"],"gpt_icon":0},{"id":"2551414194","title":"万泰生物：公司将全力以赴做好研发和经营工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2551414194","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551414194?lang=zh_cn&edition=full","pubTime":"2025-07-16 17:27","pubTimestamp":1752658020,"startTime":"0","endTime":"0","summary":"有投资者向万泰生物提问， 是否有假，连续创新低？公司回答表示，您好！二级市场股价变动受诸多因素影响，公司将全力以赴做好研发和经营工作，持续加强与市场的沟通，提升自身长期内在价值。公司将按照相关规定履行信息披露义务。感谢您对公司的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716173918a6ad2949&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716173918a6ad2949&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239"],"gpt_icon":0},{"id":"2551162771","title":"万泰生物：中标北京市红十字血液中心采购项目，中标金额为104.58万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551162771","media":"同壁财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551162771?lang=zh_cn&edition=full","pubTime":"2025-07-15 20:29","pubTimestamp":1752582593,"startTime":"0","endTime":"0","summary":"同壁财经讯，企查查数据显示，根据《[公开]乙型肝炎病毒表面抗原检测试剂盒 中标公告》，北京万泰生物药业股份有限公司于2025年7月15日公告中标北京市红十字血液中心采购项目，中标金额为104.58万元。相关上市公司：万泰生物同壁财经小贴士：万泰生物2024年营业收入为22.45亿元，营业收入增长率为-59.25%，归属母公司净利润为1.06亿元，归属母公司净利润增长率为-91.49%，净资产收益率为0.85%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715203556a44c704d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715203556a44c704d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2551913778","title":"幽门螺杆菌概念盘中跳水，*ST三圣跌0.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551913778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551913778?lang=zh_cn&edition=full","pubTime":"2025-07-15 10:17","pubTimestamp":1752545826,"startTime":"0","endTime":"0","summary":"07月15日，幽门螺杆菌概念盘中跳水，截至10点17分，幽门螺杆菌概念整体指数下跌2.09%，报1058.700点。从个股上来看，该概念的成分股中，*ST三圣跌0.20%，万泰生物、东方生物跌幅居前。从资金上来看，截止发稿，幽门螺杆菌概念概念主力净流入为-2.75亿，其中东方海洋受到资金热捧，主力净流入2.90亿；拉长时间线来看，该板块近20日主力资金净流入-64.47亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507151017069542d6ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507151017069542d6ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002742","BK0235","BK0028","688298","603392","BK0239","BK0132"],"gpt_icon":0},{"id":"2551130695","title":"生物制品行业盘中跳水，万泰生物跌0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551130695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551130695?lang=zh_cn&edition=full","pubTime":"2025-07-15 10:14","pubTimestamp":1752545650,"startTime":"0","endTime":"0","summary":"07月15日，生物制品行业盘中跳水，截至10点14分，生物制品行业整体指数下跌1.01%，报6341.440点。从个股上来看，该行业的成分股中，万泰生物跌0.14%，通化东宝、康希诺跌幅居前。从资金上来看，截止发稿，生物制品行业主力净流入为-1.47亿，其中安科生物受到资金热捧，主力净流入6409.00万；拉长时间线来看，该板块近20日主力资金净流入-33.28亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071510141097a668cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071510141097a668cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2551149029","title":"每周股票复盘：万泰生物（603392）九价HPV疫苗销售策略及海外拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=2551149029","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551149029?lang=zh_cn&edition=full","pubTime":"2025-07-13 06:50","pubTimestamp":1752360619,"startTime":"0","endTime":"0","summary":"截至2025年7月11日收盘，万泰生物报收于59.5元，较上周的60.65元下跌1.9%。本周关注点机构调研要点：公司九价HPV疫苗通过构建“区域网格化+管理数字化+服务专属化”的新型营销体系推进销售。万泰生物聚焦于体外诊断试剂和预防产品的业务领域，治疗性创新药物属于养生堂集团的业务范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300001225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","09633","LU1981816686.USD","159646","603392","BK1200","BK1589"],"gpt_icon":0},{"id":"2551914254","title":"巨头争相入局 竞逐千亿级医美赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2551914254","media":"中国产业经济信...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551914254?lang=zh_cn&edition=full","pubTime":"2025-07-13 00:00","pubTimestamp":1752336000,"startTime":"0","endTime":"0","summary":"近段时间，接连有医药企业、跨界大佬争相“杀入”医美赛道。两项交易总额达34亿元。此次权益变动后，养生堂和杭州久视合计持有锦波生物股份占比超过10%。数据显示，2025年第一季度，锦波生物实现营业收入3.66亿元，同比增长62.51%。同时，华熙生物与巨子生物的玻尿酸与重组胶原蛋白之争，则反映出医美产品快速迭代带来的竞争加剧。针对近期媒体曝光的医美领域乱象，公安部表明将采取有力措施，严厉打击相关违法犯罪活动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071307104497a3e1d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071307104497a3e1d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0146","BK0012","BK0201","600998","BK0097","BK0028","688363","BK0077","688366","BK0196","BK0187","BK0039","BK0188","BK0183","603392","BK0250"],"gpt_icon":0},{"id":"2550761912","title":"万泰生物举办资本市场专项调研会","url":"https://stock-news.laohu8.com/highlight/detail?id=2550761912","media":"新华网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550761912?lang=zh_cn&edition=full","pubTime":"2025-07-10 15:16","pubTimestamp":1752131776,"startTime":"0","endTime":"0","summary":"7月8日，北京万泰生物药业股份有限公司在厦门举办《走进万泰生物》资本市场专项调研会，调研会聚焦万泰生物在疫苗和体外诊断领域的优势与商业化能力，解析其国际化战略布局，同时介绍了公司新产品开拓情况以及未来增长潜力。万泰生物将针对不同区域人口特征、消费能力及医疗资源分布，实施差异化销售策略。本次由证券机构联合协办的机构调研会，是万泰生物与资本市场深化沟通、增进了解的重要契机。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710152942a441f8c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710152942a441f8c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239"],"gpt_icon":0},{"id":"2550697199","title":"打破高价壁垒！国产九价HPV疫苗499元上市，98%保护率+两针法（9-17岁）成亮点","url":"https://stock-news.laohu8.com/highlight/detail?id=2550697199","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550697199?lang=zh_cn&edition=full","pubTime":"2025-07-10 13:52","pubTimestamp":1752126739,"startTime":"0","endTime":"0","summary":"7月8日，万泰生物正式公布我国首款国产九价HPV疫苗“馨可宁9”定价为499元/支，约为进口九价HPV疫苗价格的40%。据最新披露的数据，截至2025年5月，仅九价HPV疫苗，万泰生物已完成研发投入约10亿元。按照接种程序，全程三针费用不足1500元，仅为进口九价HPV疫苗的三成多。业内人士指出，国产九价HPV疫苗以更高的质价比进入市场，不仅能提升适龄女性接种意愿，更为构建全民免疫屏障提供了关键支撑，将加速推动消除宫颈癌目标的实现。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710135523953d0f1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710135523953d0f1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239","159646"],"gpt_icon":0},{"id":"2550651324","title":"定价499元，大打“低价牌”万泰生物为何没能赢得市场的心？","url":"https://stock-news.laohu8.com/highlight/detail?id=2550651324","media":"大众证券报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550651324?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:19","pubTimestamp":1752067140,"startTime":"0","endTime":"0","summary":"就在一个月前，万泰生物刚刚宣布其旗下首个国产九价HPV疫苗获批上市。截至7月9日收盘，万泰生物股价报60.41元/股，较前一交易日微涨0.80%。不仅如此，如果从公布相关疫苗获批上市的消息起算，万泰生物的股价自6月6日已累计下跌超过22%。其中，四价HPV疫苗批签发47万支，同比下降95.5%；九价HPV疫苗批签发3114万支，同比下降14.8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709212033953c3195&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709212033953c3195&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2550577913","title":"2025年中国疫苗产业格局重构：九价HPV疫苗市场突破与全产业链升级分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2550577913","media":"报告大厅","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550577913?lang=zh_cn&edition=full","pubTime":"2025-07-09 08:22","pubTimestamp":1752020543,"startTime":"0","endTime":"0","summary":"截至2024年底，中国9-45岁女性HPV疫苗首针覆盖率已达27.43%，但相较于欧美国家67%的接种率仍存在显著差距，这一市场缺口正吸引着资本与技术的双重投入。临床数据显示，其自主研发的九价HPV疫苗已启动男性试验，覆盖人群范围扩大至约1.5亿适龄男性群体。目前已有8个国家和地区采用国产二价HPV疫苗作为公共卫生项目，预计九价产品通过省级招补标后将进一步渗透基层市场。通过全产业链协同创新，中国疫苗产业有望在全球健康事业中发挥更重要作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709091945953b857f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709091945953b857f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239","159646"],"gpt_icon":0},{"id":"2549154306","title":"万泰生物：7月8日接受机构调研，东方基金、红土创新基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2549154306","media":"证星公司调研","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549154306?lang=zh_cn&edition=full","pubTime":"2025-07-08 18:01","pubTimestamp":1751968860,"startTime":"0","endTime":"0","summary":"后续若有相关安排，公司将严格按照相关法律法规的要求，及时履行信息披露义务。万泰生物聚焦于体外诊断试剂和预防产品的业务领域，治疗性创新药物属于养生堂集团的业务范围。万泰生物主营业务：体外诊断试剂、体外诊断仪器与疫苗的研发、生产及销售。该股最近90天内共有2家机构给出评级，买入评级1家，增持评级1家；过去90天内机构目标均价为68.33。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708180501953ab0df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708180501953ab0df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753849867619,"stockEarnings":[{"period":"1week","weight":-0.0102},{"period":"1month","weight":-0.0406},{"period":"3month","weight":-0.0994},{"period":"6month","weight":-0.1348},{"period":"1year","weight":-0.1099},{"period":"ytd","weight":-0.1639}],"compareEarnings":[{"period":"1week","weight":0.0078},{"period":"1month","weight":0.0542},{"period":"3month","weight":0.1008},{"period":"6month","weight":0.1105},{"period":"1year","weight":0.2482},{"period":"ytd","weight":0.077}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京万泰生物药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"30955人(较上一季度增加2.21%)","perCapita":"40869股","listingDate":"2020-04-29","address":"北京市昌平区科学园路31号","registeredCapital":"126512万元","survey":"　　北京万泰生物药业股份有限公司的主营业务是体外诊断试剂、自动化检测设备、疫苗研发生产及销售。公司的主要产品是公司业务不断向多元化拓展，目前已形成了包括原料、质控品、诊断设备、免疫、生化、分子、疫苗在内的全产业链医防融合产品布局，横跨七个不同的技术平台。截至报告期末，体外诊断领域，公司拥有有效专利167项，其中发明专利117项，实用新型专利43项，外观设计7项。报告期内，公司申请专利52项，其中发明专利39项；获得授权专利26项，其中国内授权21项，国际授权5项。","listedPrice":8.75},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万泰生物(603392)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万泰生物(603392)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万泰生物,603392,万泰生物股票,万泰生物股票老虎,万泰生物股票老虎国际,万泰生物行情,万泰生物股票行情,万泰生物股价,万泰生物股市,万泰生物股票价格,万泰生物股票交易,万泰生物股票购买,万泰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万泰生物(603392)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万泰生物(603392)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}